Chang-Woo Han Selected Research

N-benzylcantharidinamide

5/2014

A novel cantharidin analog N-benzylcantharidinamide reduces the expression of MMP-9 and invasive potentials of Hep3B via inhibiting cytosolic translocation of HuR.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chang-Woo Han Research Topics

Disease

2	Neoplasms (Cancer) 01/2016 - 10/2013
1	Asthma (Bronchial Asthma) 06/2021
1	Inflammation (Inflammations) 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Lewis Lung Carcinoma 01/2016
1	Lung Neoplasms (Lung Cancer) 01/2016
1	Hepatocellular Carcinoma (Hepatoma) 05/2014
1	Neoplasm Metastasis (Metastasis) 10/2013
1	Melanoma (Melanoma, Malignant) 10/2013
1	Focal Cortical Dysplasia 01/2011
1	Synovial Sarcoma (Synovioma) 06/2008

Drug/Important Bio-Agent (IBA)

2	CytokinesIBA 01/2018 - 06/2008
1	Particulate MatterIBA 06/2021
1	antineoplaston A10 (A 10)IBA 06/2021
1	LipopolysaccharidesIBA 01/2018
1	UbiquitinIBA 01/2018
1	Cyclin D1IBA 01/2016
1	Cisplatin (Platino)FDA LinkGeneric 01/2016
1	N-benzylcantharidinamideIBA 05/2014
1	Cantharidin (Cantharides)IBA 05/2014
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 05/2014
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 10/2013
1	CXC ChemokinesIBA 10/2013
1	fucoxanthinIBA 10/2013
1	AntigensIBA 01/2011
1	Sildenafil Citrate (Viagra)FDA Link 06/2008
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2008

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2016